A.O. Smith: Great Company, Inferior Investment
April 23, 2024 Maximizing Profits: When is the Right Time to Sell Your Business?
April 12, 2024 Improve Your Financial Status: A How-To Guide
April 12, 2024 How ZIM Integrated Container Tracking is Revolutionizing Global Trade
March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5
CRISPR Therapeutics (CRSP) Stock Forecast for 2024–2028. Sell or Buy?
Updated: May 20, 2024 (06:07)
Sector: HealthcareThe share price of CRISPR Therapeutics AG (CRSP) now
50/200 Day Moving Average: $62.32 / $59.32
This figure corresponds to the Average Price over the previous 50/200 days. For CRISPR Therapeutics stocks, the 50-day moving average is the resistance level today.
For CRISPR Therapeutics stocks, the 200-day moving average is the resistance level today.
Are you interested in CRISPR Therapeutics AG stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the CRISPR Therapeutics stock price in 2024, 2025, 2026, 2027, 2028. How much will one CRISPR Therapeutics share be worth in 2024 - 2028?
When should I take profit in CRISPR Therapeutics stock? When should I record a loss on CRISPR Therapeutics stock? What are analysts' forecasts for CRISPR Therapeutics stock? What is the future of CRISPR Therapeutics stock? We forecast CRISPR Therapeutics stock performance using neural networks based on historical data on CRISPR Therapeutics stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.
CRISPR Therapeutics stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2024, 2025, 2026, 2027 and 2028) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for CRISPR Therapeutics shares. This happens once a day.
Historical and forecast chart of CRISPR Therapeutics stock
The chart below shows the historical price of CRISPR Therapeutics stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the CRISPR Therapeutics stock price can be found in the table below.
Long-term forecasts by years.
CRISPR Therapeutics AG engages in the development and commercialization of therapies derived from genome-editing technology. Its proprietary platform CRISPR/Cas9-based therapeutics allows for precise and directed changes to genomic DNA. The company was founded by Rodger Novak, Emmanuelle Charpentier, Shaun Patrick Foy, Matthew Porteus, Daniel Anderson, Chad Cowan and Craig Mellow in 2014 and is headquartered in Zug, Switzerland.
CRISPR Therapeutics daily forecast for a month
| Date | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| May 22 | 56.82 | 55.65 | 57.85 | 3.95 |
| May 23 | 56.18 | 54.95 | 56.80 | 3.37 |
| May 24 | 54.93 | 54.38 | 55.74 | 2.48 |
| May 25 | 55.18 | 54.70 | 55.62 | 1.69 |
| May 26 | 55.82 | 55.37 | 56.96 | 2.87 |
| May 27 | 56.76 | 56.13 | 57.32 | 2.12 |
| May 28 | 57.01 | 55.77 | 57.36 | 2.85 |
| May 29 | 57.60 | 56.91 | 57.94 | 1.82 |
| May 30 | 56.54 | 55.24 | 57.73 | 4.51 |
| May 31 | 56.58 | 55.57 | 56.93 | 2.44 |
| Jun 01 | 56.63 | 55.61 | 57.56 | 3.51 |
| Jun 02 | 56.00 | 55.18 | 57.28 | 3.81 |
| Jun 03 | 56.54 | 55.18 | 57.35 | 3.93 |
| Jun 04 | 57.06 | 56.26 | 58.40 | 3.80 |
| Jun 05 | 58.24 | 57.18 | 58.87 | 2.96 |
| Jun 06 | 59.73 | 58.72 | 60.84 | 3.60 |
| Jun 07 | 59.05 | 57.84 | 60.29 | 4.23 |
| Jun 08 | 60.02 | 58.96 | 60.89 | 3.27 |
| Jun 09 | 60.45 | 59.00 | 61.74 | 4.64 |
| Jun 10 | 61.00 | 60.14 | 61.99 | 3.07 |
| Jun 11 | 60.63 | 59.50 | 62.01 | 4.22 |
| Jun 12 | 61.21 | 59.82 | 61.89 | 3.47 |
| Jun 13 | 60.57 | 59.30 | 61.99 | 4.54 |
| Jun 14 | 61.63 | 60.16 | 62.94 | 4.61 |
| Jun 15 | 60.89 | 60.48 | 62.05 | 2.60 |
| Jun 16 | 60.21 | 59.63 | 61.17 | 2.57 |
| Jun 17 | 59.79 | 58.52 | 61.05 | 4.32 |
| Jun 18 | 58.45 | 57.94 | 59.54 | 2.75 |
| Jun 19 | 58.50 | 58.08 | 59.62 | 2.66 |
| Jun 20 | 57.96 | 56.67 | 58.50 | 3.22 |
CRISPR Therapeutics Daily Price Targets
CRISPR Therapeutics Stock Forecast 05-22-2024.
Forecast target price for 05-22-2024: $56.82.
Positive dynamics for CRISPR Therapeutics shares will prevail with possible volatility of 3.802%.
Pessimistic target level: 55.65
Optimistic target level: 57.85
CRISPR Therapeutics Stock Forecast 05-23-2024.
Forecast target price for 05-23-2024: $56.18.
Negative dynamics for CRISPR Therapeutics shares will prevail with possible volatility of 3.264%.
Pessimistic target level: 54.95
Optimistic target level: 56.80
CRISPR Therapeutics Stock Forecast 05-24-2024.
Forecast target price for 05-24-2024: $54.93.
Negative dynamics for CRISPR Therapeutics shares will prevail with possible volatility of 2.424%.
Pessimistic target level: 54.38
Optimistic target level: 55.74
CRISPR Therapeutics Stock Forecast 05-25-2024.
Forecast target price for 05-25-2024: $55.18.
Positive dynamics for CRISPR Therapeutics shares will prevail with possible volatility of 1.666%.
Pessimistic target level: 54.70
Optimistic target level: 55.62
CRISPR Therapeutics Stock Forecast 05-26-2024.
Forecast target price for 05-26-2024: $55.82.
Positive dynamics for CRISPR Therapeutics shares will prevail with possible volatility of 2.793%.
Pessimistic target level: 55.37
Optimistic target level: 56.96
CRISPR Therapeutics Stock Forecast 05-27-2024.
Forecast target price for 05-27-2024: $56.76.
Positive dynamics for CRISPR Therapeutics shares will prevail with possible volatility of 2.080%.
Pessimistic target level: 56.13
Optimistic target level: 57.32
CRSP (CRSP) Monthly Stock Prediction for 2024
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jun. | 56.31 | 51.26 | 59.46 | 13.79 |
| Jul. | 65.05 | 60.99 | 70.88 | 13.95 |
| Aug. | 63.07 | 55.30 | 68.72 | 19.53 |
| Sep. | 61.86 | 57.90 | 64.53 | 10.28 |
| Oct. | 64.14 | 57.67 | 68.34 | 15.62 |
| Nov. | 67.01 | 63.26 | 73.12 | 13.49 |
| Dec. | 62.40 | 59.70 | 69.89 | 14.57 |
CRISPR Therapeutics forecast for this year
CRISPR Therapeutics Stock Prediction for Jun 2024
An uptrend is forecast for this month with an optimal target price of $56.31. Pessimistic: $51.26. Optimistic: $59.46
CRISPR Therapeutics Stock Prediction for Jul 2024
An uptrend is forecast for this month with an optimal target price of $65.0493. Pessimistic: $60.99. Optimistic: $70.88
CRISPR Therapeutics Stock Prediction for Aug 2024
An downtrend is forecast for this month with an optimal target price of $63.0718. Pessimistic: $55.30. Optimistic: $68.72
CRISPR Therapeutics Stock Prediction for Sep 2024
An downtrend is forecast for this month with an optimal target price of $61.8608. Pessimistic: $57.90. Optimistic: $64.53
CRISPR Therapeutics Stock Prediction for Oct 2024
An uptrend is forecast for this month with an optimal target price of $64.1373. Pessimistic: $57.67. Optimistic: $68.34
CRISPR Therapeutics Stock Prediction for Nov 2024
An uptrend is forecast for this month with an optimal target price of $67.0106. Pessimistic: $63.26. Optimistic: $73.12
CRISPR Therapeutics Stock Prediction for Dec 2024
An downtrend is forecast for this month with an optimal target price of $62.4003. Pessimistic: $59.70. Optimistic: $69.89
CRISPR Therapeutics (CRSP) Monthly Stock Prediction for 2025
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 60.10 | 54.14 | 67.41 | 19.69 |
| Feb | 58.08 | 55.39 | 60.31 | 8.17 |
| Mar | 62.36 | 59.07 | 68.75 | 14.08 |
| Apr | 60.36 | 52.73 | 63.26 | 16.64 |
| May | 63.55 | 57.96 | 70.87 | 18.22 |
| Jun | 73.62 | 69.02 | 82.22 | 16.05 |
| Jul | 80.92 | 74.32 | 84.68 | 12.23 |
| Aug | 86.75 | 79.53 | 90.22 | 11.85 |
| Sep | 99.65 | 88.02 | 109.70 | 19.77 |
| Oct | 110.50 | 101.66 | 122.70 | 17.15 |
| Nov | 116.86 | 108.82 | 128.64 | 15.41 |
| Dec | 113.68 | 104.77 | 118.96 | 11.93 |
CRISPR Therapeutics (CRSP) Monthly Stock Prediction for 2026
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 114.05 | 105.84 | 121.53 | 12.91 |
| Feb | 106.20 | 98.21 | 112.15 | 12.42 |
| Mar | 106.20 | 98.89 | 117.59 | 15.90 |
| Apr | 101.27 | 94.31 | 107.92 | 12.61 |
| May | 106.30 | 94.05 | 114.63 | 17.95 |
| Jun | 105.96 | 100.36 | 110.03 | 8.78 |
| Jul | 109.18 | 99.39 | 118.61 | 16.20 |
| Aug | 113.20 | 100.88 | 124.61 | 19.04 |
| Sep | 97.26 | 92.59 | 101.15 | 8.46 |
| Oct | 93.68 | 89.48 | 97.72 | 8.44 |
| Nov | 95.63 | 90.27 | 102.51 | 11.94 |
| Dec | 85.68 | 79.38 | 94.18 | 15.72 |
CRISPR Therapeutics (CRSP) Monthly Stock Prediction for 2027
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 89.38 | 82.09 | 93.67 | 12.37 |
| Feb | 91.96 | 81.66 | 96.52 | 15.40 |
| Mar | 94.46 | 86.75 | 103.53 | 16.20 |
| Apr | 105.64 | 100.23 | 111.39 | 10.02 |
| May | 121.53 | 117.64 | 132.23 | 11.03 |
| Jun | 130.09 | 125.51 | 146.11 | 14.10 |
| Jul | 146.53 | 130.12 | 165.29 | 21.28 |
| Aug | 154.27 | 143.65 | 164.14 | 12.48 |
| Sep | 133.04 | 127.29 | 149.00 | 14.57 |
| Oct | 116.01 | 104.13 | 126.40 | 17.62 |
| Nov | 120.47 | 106.01 | 125.09 | 15.25 |
| Dec | 129.91 | 117.44 | 136.35 | 13.87 |
CRISPR Therapeutics (CRSP) Monthly Stock Prediction for 2028
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 149.45 | 142.27 | 165.47 | 14.02 |
| Feb | 158.77 | 146.33 | 166.65 | 12.20 |
| Mar | 153.95 | 144.09 | 163.80 | 12.03 |
| Apr | 164.54 | 150.85 | 170.33 | 11.44 |
| May | 180.33 | 161.87 | 189.28 | 14.48 |
| Jun | 199.95 | 175.32 | 212.11 | 17.35 |
| Jul | 191.32 | 179.38 | 198.66 | 9.71 |
| Aug | 215.19 | 193.50 | 239.64 | 19.25 |
| Sep | 196.60 | 184.33 | 205.72 | 10.40 |
| Oct | 202.89 | 196.40 | 222.04 | 11.55 |
| Nov | 171.73 | 153.87 | 192.61 | 20.11 |
| Dec | 150.02 | 133.94 | 162.74 | 17.70 |
CRISPR Therapeutics information and performance
BAARERSTRASSE 14, ZUG, CH
Market capitalization of the CRISPR Therapeutics AG is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of CRSP shares in the company outstanding by the market price of one share.
EBITDA of CRISPR Therapeutics is earnings before interest, income tax and depreciation of assets.
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward P/E uses projections of future earnings instead of final numbers.
Enterprise Value (EV) /Revenue
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Number of issued ordinary shares
Number of freely tradable shares
Shares Short Prior Month - the number of shares in short positions in the last month.
